A detailed history of Fortune Financial Advisors, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Fortune Financial Advisors, LLC holds 4,332 shares of CRL stock, worth $806,445. This represents 0.77% of its overall portfolio holdings.

Number of Shares
4,332
Previous 4,332 -0.0%
Holding current value
$806,445
Previous $895 Million 4.65%
% of portfolio
0.77%
Previous 0.55%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 25, 2024

BUY
$164.52 - $238.84 $30,600 - $44,424
186 Added 4.49%
4,332 $1.02 Billion
Q2 2023

Aug 07, 2023

BUY
$183.71 - $210.25 $761,661 - $871,696
4,146 New
4,146 $872 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.47B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Fortune Financial Advisors, LLC Portfolio

Follow Fortune Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fortune Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fortune Financial Advisors, LLC with notifications on news.